Concord Biotech Limited announced its first-ever 1:1 bonus issue, approved by its board on September 23. The stock rose nearly 2%, reflecting investor interest.
Concord Biotech Limited announced its first-ever 1:1 bonus issue, approved by its board on September 23. The stock rose nearly 2%, reflecting investor interest.
<iframe src="https://hindustansphere.com/embed/cluster/ecb812cb8324823624ff2ca907c319ad932a3027" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Concord Biotech 1:1 bonus issue: Jhunjhunwala family-backed pharma stock gains 50% in 6 months— record date, details"></iframe>
